Vestcor Inc Bio Techne Corp Transaction History

Vestcor Inc

$3.17 Billion
Q3 2024

A detailed history of Vestcor Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Vestcor Inc holds 3,624 shares of TECH stock, worth $273,177. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,624

Previous 3,624 -0.0%

Holding current value

$273,177

Previous $260,000 11.54%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$65.98 - $77.09 $1,583 - $1,850	-24 Reduced 0.66%	3,624 $255,000
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $1,901 - $2,815	-36 Reduced 0.98%	3,648 $281,000
Q2 2023 Aug 15, 2023	SELL	$73.76 - $85.98 $606,971 - $707,529	-8,229 Reduced 69.08%	3,684 $301,000
Q4 2022 Feb 15, 2023	BUY	$80.67 - $352.29 $666,172 - $2.91 Million	8,258 Added 225.94%	11,913 $987,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $774,442 - $1.07 Million	2,741 Added 299.89%	3,655 $1.04 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $94,219 - $131,297	292 Added 46.95%	914 $317,000
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $5,307 - $7,316	15 Added 2.47%	622 $269,000
Q4 2021 Feb 15, 2022	SELL	$456.15 - $525.06 $48,351 - $55,656	-106 Reduced 14.87%	607 $314,000
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $33,810 - $40,954	-76 Reduced 9.63%	713 $345,000
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $252,164 - $293,119	651 Added 471.74%	789 $355,000
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $252,555 - $380,760	-1,362 Reduced 90.8%	138 $36,000
Q4 2019 Feb 12, 2020	BUY	$189.68 - $222.09 $284,520 - $333,135	1,500 New	1,500 $329,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.96B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account